For many years, public health practitioners have been puzzled by the fact that vaccines
developed to fight specific diseases also have nonspecific effects that alter the host …

When the bacillus Calmette-Guérin (BCG) vaccine was introduced in the 1920s, it was
suggested that BCG occasionally had nonspecific beneficial effects on mortality beyond the …

On July 18, 2021, the world celebrated the 100th anniversary of the first administration of
Bacillus Calmette-Guérin (BCG), the only licensed vaccine against tuberculosis (TB) to date …

Differences in Bacille Calmette-Guérin (BCG) immunogenicity and efficacy have been
reported, but various strains of BCG are administered worldwide. Since BCG immunization …

Introduction BCG vaccination has been associated with beneficial non-specific effects on
child health. Some immunological studies have reported heterologous effects of vaccines on …

Background The Bacillus Calmette-Guerin (BCG) vaccine has been in use for 99 years, and
is regarded as one of the oldest human vaccines known today. It is recommended primarily …

Approximately 100 million newborn children receive Bacille Calmette–Guérin (BCG)
annually, because vaccination is consistently protective against childhood tuberculous …

Vaccines have been traditionally developed with the presumption that they exert identical
immunogenicity regardless of target population and that they provide protection solely …

Abstract Background Bacille Calmette-Guérin (BCG) vaccination has important non-specific
immune effects. In a randomized trial in Guinea-Bissau, BCG revaccination was associated …

Bacillus Calmette–Guérin (BCG) vaccine provides good protection against disseminated
mycobacterial diseases such as miliary tuberculosis, tuberculous meningitis, and leprosy [1 …